Universal Corporation

Universal Corporation (UVV) Market Cap

Universal Corporation has a market capitalization of $1.34B.

Price: $53.76

0.89 (1.68%)

Market Cap: 1.34B

NYSE · time unavailable

CEO: Preston Douglas Wigner

Sector: Consumer Defensive

Industry: Tobacco

IPO Date: 1988-01-05

Website: https://www.universalcorp.com

Universal Corporation (UVV) - Company Information

Market Cap: 1.34B|Sector: Consumer Defensive

Company Profile

Universal Corporation processes and supplies leaf tobacco and plant-based ingredients worldwide. The company operates through two segments, Tobacco Operations and Ingredients Operations. It is involved in the procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products. The company contracts, purchases, processes, and sells flue-cured, burley, and oriental tobaccos that are primarily used in the manufacture of cigarettes; and dark air-cured tobaccos principally used in the manufacture of cigars, natural wrapped cigars and cigarillos, smokeless, and pipe tobacco products. It also provides value-added services, including blending, chemical, and physical testing of tobacco; service cutting for various manufacturers; manufacturing reconstituted leaf tobacco; just-in-time inventory management services; electronic nicotine delivery systems; and smoke testing services for customers. In addition, the company offers testing services for crop protection agents and tobacco constituents in seed, leaf, and finished products, including e-cigarette liquids and vapors; and analytical services that include chemical compound testing in finished tobacco products and mainstream smoke. Further, it provides a various value-added manufacturing processes to produce specialty vegetable and fruit-based ingredients, as well as botanical extracts and flavorings for human and pet food markets; and recycles waste materials from tobacco production. The company was founded in 1886 and is headquartered in Richmond, Virginia.

Analyst Sentiment

50%
Hold

From 0 Active Polls

Consensus Target Matrix

Data feed parsing pending...

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$56.45
▲ +5.00% Upside
Low Target
$40.32
-25% Risk
Median Target
$54.84
2% Mid
High Target
$67.20
25% Max
Consensus
Buy
1 / 1 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,3401,3201,3221,3991,4561,4001,3701,3251,185
Enterprise Value ($M)2,2182,1982,3502,5042,5532,2452,3412,4712,309
Price to Earnings Ratio (P/E)41.27-7.639.9410.2342.8437.495.7412.772279.02
Price/Earnings-to-Growth Ratio (PEG)0.700.380.180.67
Price to Sales Ratio (P/S)0.461.851.531.852.451.991.461.861.98
Price to Book Ratio (P/B)0.950.930.890.951.000.960.940.930.84
Price to Free Cash Flow Ratio (P/FCF)16.697.3913.9059.02-6.709.276.87-1304.05-13.91
Enterprise Value to Sales (EV/Sales)3.072.733.324.303.202.503.483.87
Enterprise Value to EBITDA (EV/EBITDA)8.7384.2225.0130.7448.6840.3419.7229.7269.55
Debt to Equity Ratio3.460.660.750.810.870.760.820.860.87

UVV Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$53.76
Intrinsic Value$29.90
Market Alignment
Overvalued by 44.4%relative to calculated intrinsic value
9.00%
Exp: -0%-0%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2036)

Terminal FCF Base$0.12B
Perpetuity TV Value$2.25B
Discounted TV (PV)$0.87B
TV Weighting %54.3%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 UNIVERSAL CORP (UVV) — Investment Overview

🧩 Business Model Overview

UNIVERSAL CORP operates as a global tobacco leaf dealer and processor. The core value chain spans (1) sourcing tobacco leaf from a geographically diversified grower base, (2) processing and conditioning leaf to meet customer specifications, (3) warehousing and logistics to manage timing and quality, and (4) selling processed leaf to cigarette and cigar manufacturers worldwide.

Customer stickiness is driven by the need for consistent leaf quality, reliable delivery windows, and qualification processes at manufacturing facilities. Cigarette makers and cigar manufacturers typically qualify suppliers for blend performance and operational continuity, which makes resourcing more than a simple commodity purchase.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated from tobacco leaf sales (including processed and conditioned leaf) to major tobacco product manufacturers. Monetisation is largely transactional, but it is underpinned by repeat purchasing and qualification continuity rather than pure one-off spot trading.

Margin drivers include (1) leaf procurement economics (pricing and purchasing discipline relative to market conditions), (2) processing and quality conversion value (upgrading leaf into salable grades and specs), and (3) logistics/handling efficiency that reduces spoilage, quality loss, and time-to-sale.

Working capital dynamics matter: the business must fund inventory and procurement cycles, so spreads and inventory turnover influence earnings quality over time, even when end-demand remains stable.

🧠 Competitive Advantages & Market Positioning

  • Cost & scale advantage in procurement: Broad sourcing relationships across growing regions improve access to suitable leaf types and reduce exposure to single-region crop variability.
  • Quality-processing capability (operational moat): Processing, conditioning, and grading know-how supports consistent performance for downstream blending requirements.
  • Customer qualification and continuity: End-manufacturers face blend-performance and supply-continuity constraints, creating a practical barrier to switching suppliers.

Competitive benchmarking: Primary comparables include Alliance One International, One Stop Systems (OTC) leaf merchant peers—and other regional tobacco leaf processors/merchants such as Dimon Inc. While many competitors participate in parts of the leaf-processing and trading value chain, UNIVERSAL CORP’s positioning emphasizes a diversified processing and merchandising footprint with a focus on delivering qualified leaf specifications to large downstream manufacturers. Rivals often vary more in (a) geographic reach, (b) processing depth across leaf types, and (c) ability to supply consistent grades through procurement cycles.

UNIVERSAL CORP’s moat is therefore less about brand and more about procurement economics, processing conversion, and supply qualification durability.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is more likely to come from mix and execution than from simple volume expansion. Key drivers include:

  • Global cigarette manufacturing demand for consistent leaf inputs: Even with category pressure in some markets, downstream manufacturers must source qualified leaf for existing production portfolios and regulatory-compliant blends.
  • Improving processing mix and grade outcomes: Better conversion of purchased leaf into higher salable grades can enhance value capture without proportionate inventory risk.
  • Geographic diversification of supply: A diversified grower and logistics footprint can stabilize sourcing economics when weather, acreage, or local policy shifts affect specific regions.
  • Long-run supplier qualification cycles: Supplier onboarding and qualification typically require time; maintaining performance standards supports multi-year relationships.

TAM expansion is best viewed through the lens of value per pound and market share within qualified supply chains rather than broad incremental penetration.

⚠ Risk Factors to Monitor

  • Commodity and cycle risk: Tobacco leaf is a crop-driven input with variability in supply, pricing, and quality. Earnings can be sensitive to procurement timing and inventory cost.
  • Credit and working-capital risk: Funding inventory and settling counterparties requires disciplined credit management and robust cash conversion.
  • Regulatory and litigation pressure on end markets: Tobacco-related regulation, excise taxes, and litigation can pressure downstream volumes, which then filters back to leaf demand.
  • Operational and quality risk: Processing performance, warehousing conditions, and spoilage management directly affect salable yield and margins.
  • Concentration risk: Revenue exposure to a limited set of large downstream manufacturers can increase negotiation leverage against suppliers.

📊 Valuation & Market View

The market typically values tobacco leaf dealers on a blend of earnings power and cycle-adjusted cash generation. Trading ranges are often influenced by:

  • Operating margins driven by procurement economics, processing yield, and logistics efficiency.
  • Working capital behavior, particularly inventory turns and funding requirements across procurement cycles.
  • Risk perception tied to commodity volatility and the credit profile of counterparties.

In practice, valuation frameworks commonly reference EV/EBITDA or earnings-based multiples, with attention to how durable margins are through different leaf-cycle conditions.

🔍 Investment Takeaway

UNIVERSAL CORP’s long-term thesis rests on a structural “how-to” moat: disciplined procurement across diversified growing regions, processing and conditioning capabilities that convert raw leaf into consistently qualified inputs, and customer continuity stemming from qualification and blend-performance needs. While the business is exposed to commodity cycles and end-market regulation, the durability of relationships and the operational conversion of leaf into saleable grades provide a credible platform for compounding value through varying supply-demand conditions.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for UVV.

247wallst.com2026-06-04

Billionaire Bill Ackman's Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Bill Ackman's Pershing Square has closed the book on one of its most ambitious activist campaigns.

businesswire.com2026-06-04

Universal Display Corporation to Hold Virtual 2026 Annual Meeting of Shareholders

EWING, N.J.--(BUSINESS WIRE)---- $OLED #OLED--Universal Display Corporation to hold virtual 2026 Annual Meeting of Shareholders on June 18, 2026, at 10:00 a.m. ET.

proactiveinvestors.com2026-06-04

Universal Music Group shares fall after Ackman's Pershing Square exits remaining stake

Universal Music Group (AEX:UMG) shares fell on Thursday after Bill Ackman's Pershing Square Capital Management sold its remaining holding in the music company, bringing an end to a five-year investment. According to media reports, Pershing Square sold approximately 80.6 million UMG shares through a private placement at €17.66 per share, representing roughly an 8% discount to Wednesday's closing price.

reuters.com2026-06-04

Universal Music buys back part of Ackman's Pershing stake after $64 billion bid fails

Universal Music Group said on Thursday it has repurchased some of the shares sold by Bill Ackman's Pershing Square , after ​the billionaire investor's takeover proposal for the music company was rejected.

invezz.com2026-06-04

Universal Music shares fall as Ackman sells $1.5B stake

Universal Music shares fell on Thursday after billionaire investor Bill Ackman's Pershing Square Capital Management sold its remaining stake in the world's largest music company, ending a five-year investment that is expected to generate profit of at least $600 million. The disposal involved approximately 80.6 million Universal Music shares valued at more than $1.5 billion, according to a Wall Street Journal report.

wsj.com2026-06-04

Universal Music Shares Fall After Ackman Fund Offloads $1.5 Billion Stake

Universal Music Group shares deepened their year-to-date loss after Pershing Square exited the world's biggest music company five years after its initial investment.

wsj.com2026-06-03

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake

The hedge-fund firm first invested in the company in 2021 and has failed to clinch two proposed deals.

globenewswire.com2026-06-03

OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document

OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document

reuters.com2026-06-03

Ackman's Pershing set to exit Universal Music Group stake, Bloomberg News reports

Bill Ackman's Pershing Square is looking to sell ​its stake in Universal Music Group , ‌Bloomberg News reported on Wednesday, days after the music industry giant rebuffed the billionaire investor's ​takeover proposal.

seekingalpha.com2026-06-03

Universal Corp: The Three Reasons Why I Am Downgrading To Hold

Universal Corp (UVV) faces ongoing top- and bottom-line pressure due to persistent tobacco oversupply and margin compression. I shift from a buy to a hold rating, awaiting evidence of top-line growth and improved profitability before turning bullish again. UVV's 6.13% dividend yield remains attractive, but dividend safety is in question as free cash flow barely covers payouts.

businesswire.com2026-06-02

Universal Display Corporation Expands China Presence with Grand Opening of Chengdu OLED Technology and Innovation Center

EWING, N.J. & CHENGDU, China--(BUSINESS WIRE)---- $OLED #OLED--UDC announced the grand opening of its OLED Technology and Innovation Center in Chengdu, China.

prnewswire.com2026-06-02

Hydro Flask® and Universal Music Group Partner to Promote Reusable Drinkware in Music Spaces

Hydro Flask will work across UMG's global network of studios, songwriting sessions, and events to encourage the reduction of single-use beverageware by integrating reusable hydration solutions Launching with a special event at the iconic Abbey Road Studios, the sustainability-focused global collaboration will unfold throughout the year with activations and events featuring Gigi Perez, Sekou, and additional surprise artists LOS ANGELES and LONDON, June 2, 2026 /PRNewswire/ -- Hydro Flask® , an award-winning leader in high-performance insulated products, and Universal Music Group (UMG), the world leader in music-based entertainment, today announce a new global partnership to encourage the reduction of single-use beverage waste within the music industry. Built as a long-term creative collaboration — from songwriting sessions and recording studios to live events and artist experiences — Hydro Flask will support the artists, songwriters, producers and fans shaping culture by creating access to reusable hydration solutions that minimize impact on the natural environments that inspire creativity.

prnewswire.com2026-06-01

Universal Music Group N.V. Reports Weekly Transactions under its €500 Million Share Buyback Program

HILVERSUM, The Netherlands, June 1, 2026 /PRNewswire/ -- Universal Music Group N.V. (EURONEXT: UMG) ("UMG" or "the Company") today announced that in the period from May 25, 2026 up to and including May 29, 2026 a total of 711,279 of its own shares were repurchased by the Company at an average price per share of €20.01 for a total consideration of €14,233,389. These repurchases have been made as part of the Company's €500 million share buyback program as announced on March 30, 2026.

wsj.com2026-05-29

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman

Universal's biggest shareholder is opposed to deal, saying it undervalued the world's largest music company.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"UVV reported Q4’26 (ended 2026-03-31) revenue of $0 and net income of -$43.3M (EPS -$1.73), representing a sharp deterioration versus Q3’26 (revenue $861.3M, net income +$33.2M). Revenue and net income quality in this quarter appear distorted by the reported zero revenue line, so trend conclusions are directionally based on profitability and cash flow rather than absolute revenue levels. QoQ, net income swung from +$33.2M to -$43.3M (down ~$76.5M). YoY comparison to 2025-03-31 is also unfavorable on profitability: net income moved from +$9.3M to -$43.3M (down ~$53.4M). Operating margin contracted materially, with operating income at -$14.1M versus +$81.0M in Q3’26. Cash flow was strong on an operating basis: operating cash flow was +$435.3M and free cash flow +$508.6M, even as dividends were paid (-$35.3M) and the company remained levered (net debt -$939.8M per the dataset sign convention). The key risk in Q4’26 is the earnings collapse alongside heavy investing/capex-level outflows. Shareholder returns are muted by price performance: market price is $52.46, with only +3.19% 1y_change. No buybacks were reported in the quarter, so total return is likely dividend- and ops-cash-flow driven rather than momentum."

Revenue Growth

Neutral

Revenue is reported as $0 in 2026-03-31 versus $861.3M in 2025-12-31, making QoQ/trajectory assessment unreliable. YoY revenue is also not comparable due to the zero reported line in the latest quarter.

Profitability

Neutral

Net income fell from +$33.2M (2025-12-31) to -$43.3M (2026-03-31), and EPS dropped to -$1.73. Operating income swung from +$80.96M to -$14.05M; margins contracted sharply.

Cash Flow Quality

Neutral

Despite the earnings loss, operating cash flow was +$435.3M and free cash flow was +$508.6M. Dividends were still paid (-$35.3M), suggesting some coverage, but the investing outflow burden was elevated.

Leverage & Balance Sheet

Caution

Equity increased to about $1.46B (2026-03-31) from ~$1.53B (2025-12-31). Debt remains substantial (total debt ~$939.8M per dataset), so resilience depends on continued cash generation.

Shareholder Returns

Neutral

Price momentum is modest: +3.19% over 1y. No buybacks reported in Q4’26; return appears more reliant on dividends/cash generation than on valuation expansion.

Analyst Sentiment & Valuation

Neutral

No price target provided. Trading metrics in the dataset for the latest quarter are not meaningful (e.g., zeros/invalids), limiting conviction on valuation versus fundamentals.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

UVV’s Q4 FY2026 results were pressured despite modest revenue growth, with an operating loss driven by noncash Shank’s goodwill impairment ($41M) and larger tobacco inventory write-downs, especially non-wrapper dark air-cured tobacco. Tobacco revenue rose in Q4 (up 3%), but segment operating income fell materially, reflecting the same inventory-related accounting impacts. Ingredients revenue edged down in Q4 and full-year ingredients profit declined, attributed to Shank’s performance plus higher fixed costs from product pipeline build. Management’s FY2027 focus is normalization and execution: they guided uncommitted inventory to remain within 10%–20%, citing early movement since March 31 and comfort from the Q4 deep inventory review. For operations, they implemented Shank’s leadership realignment to improve commercial execution and facility utilization. Key risks remain oversupply dynamics, continued tariff/inflation variability, and the time required to convert ingredients customer interest into durable revenue and margins. Sentiment is cautious but grounded in confident inventory positioning and clear execution actions.

AI IconGrowth Catalysts

  • Shank’s leadership realignment to strengthen commercial execution, improve facility utilization, and enhance financial/operational efficiency
  • Tobacco strategy emphasizing geographic diversification and correct grade/price buying under continued global oversupply
  • Ingredients platform execution to convert pipeline investments into sustained revenue and margin growth despite ongoing inflation and market headwinds

Business Development

  • CDP Supplier Engagement Assessment: moved from A- to A rating and named to CDP Supplier Engagement A list (supplier engagement/gov/emissions collaboration signal)
  • No named customers/partners/vendors disclosed in Q&A or prepared remarks; growth discussion centered on Shank’s execution and tobacco customer relationships

AI IconFinancial Highlights

  • Q4 consolidated revenue: $715M, up 2% YoY; full-year revenue: $2.9B, down slightly vs FY2025
  • Q4 operating loss: $(15)M vs operating income of $43M YoY; full-year operating income: $169M, down $64M vs FY2025
  • Net loss attributable to Universal in Q4: $(43)M vs net income of $9M YoY; full-year net income: $33M vs $95M in FY2025
  • Primary drivers: $41M noncash goodwill impairment at Shank’s (recorded in FY2026) and higher inventory write-downs in non-wrapper dark air-cured tobacco
  • Tobacco segment Q4 revenue: $632M, up 3% YoY; full-year tobacco revenue: $2.6B, down slightly
  • Tobacco segment operating income: $27M in Q4 vs $46M YoY; full-year tobacco operating income: $212M vs $240M
  • Inventory write-downs (tobacco segment): $43M in FY2026 vs $19M in FY2025 (vs $14M average across FY2021–FY2025)
  • Ingredients segment Q4 revenue: $83M vs $90M YoY; full-year ingredients revenue: $348M, up 3%
  • Ingredients segment operating income: $2M in Q4 vs $4M YoY; full-year ingredients operating income: $3M vs $12M (lower profitability tied to Shank’s and higher fixed/operating costs for product pipeline investments)

AI IconCapital Funding

  • Net debt as of March 31, 2026: $845M vs $817M at March 31, 2025 (increase tied to higher working capital usage from purchasing/selling a significantly larger tobacco crop)
  • Liquidity availability totaled over $1.2B (cash plus committed and uncommitted credit lines)
  • No share repurchase dollar amounts, debt maturities, or buyback program quantities disclosed in the transcript

AI IconStrategy & Ops

  • Noncash goodwill impairment at Shank’s: goodwill recorded ~$41M at acquisition (Oct 2021); impairment concluded after valuation analysis due to pressured revenues/profitability and lag in commercial execution vs strategy amidst market headwinds
  • Operational/accounting: inventory valued at lower of cost or net realizable value; management performed a deep dive in Q4 to determine FY2026 write-down estimates
  • Shank’s organizational realignment: leadership-level changes aimed at commercial execution, facility utilization, and financial/operational efficiency
  • FY2027 posture: maximize/optimize tobacco business, grow ingredients with disciplined execution, and strengthen overall durability

AI IconMarket Outlook

  • Uncommitted inventory guidance/range: management confident they will be within 10%–20% during fiscal 2027 (based on movement already seen since March 31, 2026; better update planned for the fiscal 2027 first-quarter call)
  • Tariff outlook: expects normalization could reduce inflationary pressure; but tariffs may remain fluid

AI IconRisks & Headwinds

  • Continued oversupply in certain tobacco styles carrying over from FY2026 oversupply transition, with large global crops expected in flue-cured and burley
  • Ingredients headwinds: continued market headwinds impacting volumes/margins and higher fixed/operating costs from growth investments/product pipeline build
  • Inventory risk: non-wrapper, dark air-cured tobacco write-downs resulted from thorough end-of-year review and current market dynamics
  • Shank’s execution risk: commercial strategy lag and conversion of customer interest into sustained revenue/margin growth can be lengthy
  • Macro/policy: inflationary pressure and tariff impacts (management emphasized navigating tariff impacts in FY2026 and expects persistence/variability)

Q&A: Analyst Interest

  • Topic: Inventory normalization and additional dark air-cured write-down risk in FY2027: Management said the disclosed inventory figure is as of March 31, 2026 and noted early buying in Brazil with observed movement in the prior two months. They guided confidence for uncommitted inventory of 10%–20% in fiscal 2027 and emphasized comfort after Q4 write-down depth and ongoing quarterly-style monitoring under accounting rules.
  • Topic: Underlying FY2027 trends in flue-cured, burley, and ingredients (outside Shank’s): Management highlighted early season conditions, large crops globally, and oversupply carryover. They stressed geographic diversification, strategic purchasing of grades/prices, and customer demand monitoring. For ingredients, they referenced persistent inflation/tariffs, but expressed encouragement in navigating headwinds and leveraging Shank’s platform investments for improved efficiency and profitability.
  • Topic: Capital allocation priorities and how to balance dividend with ingredients investment: Management reaffirmed four-pillar strategy (invest in tobacco growth, increase dividend, explore plant-based ingredients growth, return excess via repurchases). They cited dividend payout ratio on reported net income over 100% this year, but adjusted basis below 75% over five years, indicating dividend funding support. For ingredients, they emphasized organic investment now entering return-realization phase post-2021 Shank’s expansion, not near-term new acquisitions.

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the UVV Q4 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for UVV.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (UVV)

© 2026 Stock Market Info — Universal Corporation (UVV) Financial Profile